Natco Pharma mulling acquisition in RoW market to strengthen base business

Natco Pharma is mulling acquisitions in the Rest of the World (RoW) markets to strengthen its base business.

“The acquisition space is to strengthen our base business. We have the money to do it and are looking at Rest of the World business. As of now, we are not able to close anything, but we are hoping in the next couple of years,’‘ Rajeev Nannapaneni, Director and CEO, Natco Pharma said.

On the plans for any buyback plans by the promoters, he said no decision was taken in the regard so far. “We get a large-enough acquisition then I don’t want to do a buyback. But if we are unable to close a large acquisition, then maybe we can consider a buyback. We will decide as the year unfolds.’

Hyderabad-based Natco has been taking steps to expand its reach and recently invested approximately $2 million in Cellogen Therapeutics Private Ltd, a Delhi based biotech start-up.

As the company is strong in oncology, it might augur well for its business going forward. “We feel that a lot of the oncology therapy is going to go to CAR-T. We have the option to invest more, depending on how things go as we had a modest start,’‘ he said.

AGRO Business

On the plans for the agri business he said in FY24, while the company aimed at ₹140 -₹150 crore business, it fell short by about ₹25 crore. “The monsoon was bad last year and we had some returns. Overall, I think it’s a good business. We build a reasonably brand business in a very short duration of time. We can give specific guidance of how the business is going around June quarter,’‘ he added.

Natco is `optimistic’ about a number of first-time generics in agro business going forward.

The company recorded its highest ever consolidated revenue and profits during the last financial year. In FY24, it posted consolidated revenue of ₹4,127 crore as against ₹2,811 crore in the previous year reflecting about 47 per cent growth. The consolidated net profit for the year was ₹1,388 crore as against ₹715 crore FY23 showing a growth of 94 per cent.

Related Posts

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

New Delhi: In a sweeping international crackdown, the Narcotics Control Bureau (NCB) and the US Drug Enforcement Administration (DEA) have dismantled the Indian nerve center of a massive transnational drug…

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Commissioner of Food Safety Tukaram Mundhe said inspections, consumer complaints and surveillance had repeatedly revealed violations Repeated violations of existing food safety regulations by manufacturers and sellers of health supplements…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines